Haematological Malignancy clinical trials

Explore recruiting haematological malignancy clinical trials.

Recruiting haematological malignancy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Haematological Malignancy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Fecal Microbiota Transplantation in the prevention of complications after allogeneic hematopoietic stem cell transplantation for hematologic malignancy

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Actuate 1801: Phase 1/2 Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3 Beta (GSK-3β) Inhibitor, as a Single Agent and Combined with Chemotherapy, in Patients with Refractory Hematologic Malignancies or Solid Tumors

Portugal, Belgium, France, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1 Study of HMPL-306 in Advanced Hematological Malignancies with Isocitrate Dehydrogenase (IDH) Mutations

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Haematological Malignancy trials by city

Haematological Malignancy in Toronto Haematological Malignancy in Vancouver Haematological Malignancy in Montreal Haematological Malignancy in Calgary Haematological Malignancy in Edmonton Haematological Malignancy in Ottawa Haematological Malignancy in Winnipeg Haematological Malignancy in Quebec City Haematological Malignancy in Hamilton Haematological Malignancy in Kitchener Haematological Malignancy in London Haematological Malignancy in Halifax Haematological Malignancy in New York Haematological Malignancy in Los Angeles Haematological Malignancy in Chicago Haematological Malignancy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease